Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

Author： Naumova Elissaveta Mihaylova Anastassia Ivanova Milena Mihailova Snejina

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.56, Iss.1, 2007-01, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors – Considerations for Successful Immunotherapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1094-1100

Bentham Science Publishers

Access to resources Recommend Favorite

Differential Responses to Chemoimmunotherapy in Patients with Metastatic Malignant Melanoma

By Mainwaring P.N. Atkinson H. Chang J. Moore J. Hancock B.W. Guillou P.J. Oskam R. Gore M.E.

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1388-1392

Elsevier

Access to resources Recommend Favorite

HLA class I antigen abnormalities and immune escape by malignant cells

By Seliger B. Cabrera T. Garrido F. Ferrone S.

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 3-13

Academic Press

Access to resources Recommend Favorite

Immune selective pressure and HLA class I antigen defects in malignant lesions

By Chang Chien-Chung Ferrone Soldano

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite

Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite